Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manuelle Viguier

Showing results (111-120 of 116) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 116 results.
The British Journal of Dermatology|May 11, 2026
Incidence and Mortality of Mucous Membrane Pemphigoid in FranceAlexis Lefebvre, André Gillibert, Emmanuelle Tancrede-Bohin, et al.
Joint Bone Spine|May 1, 2012
Abatacept therapy and safety managementThao Pham, Hervé Bachelez, Jean-Marie Berthelot, et al.
The Journal of Allergy and Clinical Immunology. in Practice|December 13, 2024
Switching From Dupilumab to Tralokinumab or Janus Kinase Inhibitors in Cases of Ocular and/or Facial Adverse Events in Patients With Atopic Dermatitis: A Multicenter Retrospective StudyAlexandre Beyrouti, Juliette Deuze, Eric Fontas, et al.
European Journal of Cancer (Oxford, England : 1990)|March 10, 2026
Cemiplimab versus historical systemic treatments for locally advanced or metastatic cutaneous squamous cell carcinomas: Results from the French study TOSCACaroline Robert, Emilie Gérard, Emilie Lanoy, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|February 2, 2023
Multicenter prospective observational study of dupilumab-induced ocular events in atopic dermatitis patientsIngrid Costedoat, Martin Wallaert, Aurelie Gaultier, et al.
Joint Bone Spine|June 28, 2011
TNF alpha antagonist therapy and safety monitoringThao Pham, Hervé Bachelez, Jean-Marie Berthelot, et al.
Pageof 12

Showing results (111-120 of 116) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 116 results.
The British Journal of Dermatology|May 11, 2026
Incidence and Mortality of Mucous Membrane Pemphigoid in FranceAlexis Lefebvre, André Gillibert, Emmanuelle Tancrede-Bohin, et al.
Joint Bone Spine|May 1, 2012
Abatacept therapy and safety managementThao Pham, Hervé Bachelez, Jean-Marie Berthelot, et al.
The Journal of Allergy and Clinical Immunology. in Practice|December 13, 2024
Switching From Dupilumab to Tralokinumab or Janus Kinase Inhibitors in Cases of Ocular and/or Facial Adverse Events in Patients With Atopic Dermatitis: A Multicenter Retrospective StudyAlexandre Beyrouti, Juliette Deuze, Eric Fontas, et al.
European Journal of Cancer (Oxford, England : 1990)|March 10, 2026
Cemiplimab versus historical systemic treatments for locally advanced or metastatic cutaneous squamous cell carcinomas: Results from the French study TOSCACaroline Robert, Emilie Gérard, Emilie Lanoy, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|February 2, 2023
Multicenter prospective observational study of dupilumab-induced ocular events in atopic dermatitis patientsIngrid Costedoat, Martin Wallaert, Aurelie Gaultier, et al.
Joint Bone Spine|June 28, 2011
TNF alpha antagonist therapy and safety monitoringThao Pham, Hervé Bachelez, Jean-Marie Berthelot, et al.
Pageof 12